ESR1 and breast neoplasm: Estrone, the biologically active form of estrogen, is converted into two different metabolites: 2-hydroxyestrone (2OHE1) (with small biological activity) and 16α-hydroxyestrone (16OHE1), which enhances estrogen activity and promotes cell proliferation, particularly in estrogen receptor-positive (ER+) breast tumors.